Nanoscale · 2019 · 40 citations · 19 references
MedicineCancer BiologyOncologyBiophotonicsCancer PharmacologyTheranosticsCancer TheranosticsGlutathione MetabolismPhotothermal TherapyTheranostic ApproachesTheranostics In OncologyTumor ImagingCancer Photothermal TherapyOncologic TheranosticsPhotoacoustic Contrast AgentsPhotoacoustic ProbesPhotosensitizersPhotothermal Ablation Of TumorsTargeted Photothermal TherapyTheranostic Agents
Nowadays, Fenton reaction-based chemodynamic therapy (CDT) strategies have drawn extensive attention as tumor-specific nanomedicine-based therapy. Nevertheless, current existing CDTs normally suffer from therapeutic bottlenecks such as the scavenging of hydroxyl radical (˙OH) by intracellular antioxidants and unideal therapeutic outcome of single treatment modality. Herein, we constructed novel all-in-one AFP nanoparticles (NPs) as CDT agents through a one-pot process for multifunctional nanotheranostics. The as-constructed AFP NPs could simultaneously produce ˙OH through the Fenton reaction and scavenge intracellular glutathione, functioning as self-reinforced CDT agents to achieve tumor-triggered enhanced CDT (ECDT). In addition, the AFP NPs possessed the capability of H2O2 and acid-boosted photoacoustic imaging and photothermal therapy, enabling a precise and effective tumor therapeutic outcome with minimal nonspecific damage in combination with ECDT. Our novel nanoplatform would open new perspectives on multi-functional CDT agents for accurate and non-invasive tumor theranostics.
19
Tumor-selective catalytic nanomedicine by nanocatalyst delivery
Minfeng Huo, Liying Wang, Yu Chen et al. · Nature Communications · 2017 · 1.3K citations · Full text